Validation of plasma biomarker immunoassay‐based models for predicting brain amyloid positivity in cognitively impaired individuals

by Clinical Neuropsychologist Online | Wednesday, November 4, 2026 | Dementia

Abstract INTRODUCTION Combining Alzheimer’s disease blood biomarkers may improve prediction of amyloid positivity (A+) compared with single biomarkers. METHODS Logistic regression models using plasma phosphorylated tau 217 (p-tau217), amyloid beta (Aβ) 42, and...

Correction to “Gamma sensory stimulation in mild Alzheimer’s dementia: An open‐label extension study”

by Clinical Neuropsychologist Online | Wednesday, November 4, 2026 | Dementia

Alzheimer’s &Dementia, Volume 22, Issue 11, November 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | November 4, 2026 Neuro-Dementia...

The Experiences of Psychotherapy for People With Dementia: A Qualitative Interview Study With Family Members

by Clinical Neuropsychologist Online | Tuesday, November 3, 2026 | Dementia

Dementia, Ahead of Print. Psychotherapeutic interventions can support people with dementia. Family members often play a pivotal role in the therapeutic process but little is known about their experiences of therapy, how they perceive the impact on their relative, and...

Objective sleep characteristics and longitudinal change in financial and health literacy in older adults

by Clinical Neuropsychologist Online | Sunday, November 1, 2026 | Dementia

Abstract INTRODUCTION Sleep disturbances are common in older adults and linked to cognitive decline, but their association with functional abilities such as financial and health literacy is less understood. METHODS Participants without dementia from the Rush Memory...

Chronic kidney disease and blood‐based biomarkers of Alzheimer’s disease: the brain in kidney disease study

by Clinical Neuropsychologist Online | Sunday, November 1, 2026 | Dementia

Abstract BACKGROUND Reduced kidney function affects the levels of many Alzheimer’s disease and related dementias (ADRD) blood-based biomarkers (BBMs). The extent to which kidney function is associated with serum levels of brain-derived tau (BD-tau), a novel BBM...

Association of neighborhood deprivation with Alzheimer’s disease pathology, brain structure, and cognition by race and ethnicity, sex, and APOE ε4 status

by Clinical Neuropsychologist Online | Sunday, November 1, 2026 | Dementia

Abstract INTRODUCTION We investigated associations of Area Deprivation Index (ADI) with Alzheimer’s disease (AD) -related outcomes by biological and social factors in at-risk older adults. METHODS A total of 1880 U.S. POINTER participants with ADI and cognition...